Belén Chaves-Arquero

Dr. Belén Chaves-Arquero

Centro de Investigaciones Biológicas Margarita Salas, Madrid, Spain
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2020 in Chemistry – A European Journal
Verified
Journal Article
Closed access
PDF file
BCBelén Chaves-Arquero
Belén Chaves-Arquero
JPJosé Manuel Pérez-Cañadillas
José Manuel Pérez-Cañadillas
M Angeles JimenezM Angeles Jimenez
M Angeles Jimenez

9 November 2018 in Journal of Biomolecular NMR
Verified
Journal Article
Closed access
PDF file
BCBelén Chaves-Arquero
Belén Chaves-Arquero
DPDavid Pantoja-Uceda
David Pantoja-Uceda
ARAlicia Roque
Alicia Roque
IPInmaculada Ponte
Inmaculada Ponte
PSPedro Suau
Pedro Suau
M Angeles JimenezM Angeles Jimenez
M Angeles Jimenez

3 November 2019 in EMBO Reports
Verified
Journal Article
Open access
PDF file
MMManuel Martín‐Expósito
Manuel Martín‐Expósito
MGMaria‐Eugenia Gas
Maria‐Eugenia Gas
NMNada Mohamad
Nada Mohamad
CNCarme Nuño‐Cabanes
Carme Nuño‐Cabanes
ATAna Tejada‐Colón
Ana Tejada‐Colón
Susana Rodriguez-NavarroSusana Rodriguez-Navarro
Susana Rodriguez-Navarro
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

24 May 2023 in Biochemical Society Transactions
Verified
Journal Article
Open access
PDF file
BCBelén Chaves-Arquero
Belén Chaves-Arquero
JPJosé Manuel Pérez-Cañadillas
José Manuel Pérez-Cañadillas
A substantial part of living cells activity involves transcription regulation. The RNA polymerases responsible for this job need to know ‘where/when' to start and stop in the genome, answers that may change throughout life and upon external stimuli. In Saccharomyces cerevisiae, RNA Pol II transcription termination can follow two different routes: the poly(A)-dependent one used for most of the mRNAs and the Nrd1/Nab3/Sen1 (NNS) pathway for non-coding RNAs (ncRNA). The NNS targets include snoRNAs and cryptic unstable transcripts (CUTs) generated by pervasive transcription. This review recapitulates the state of the art in structural biology and biophysics of the Nrd1, Nab3 and Sen1 components of the NNS complex, with special attention to their domain structures and interactions with peptide and RNA motifs, and their heterodimerization. This structural information is put into the context of the NNS termination mechanism together with possible prospects for evolution in the field.

12 January 2022 in Life Science Alliance
Verified
Journal Article
Open access
PDF file
BCBelén Chaves-Arquero
Belén Chaves-Arquero
SMSantiago Martínez-Lumbreras
Santiago Martínez-Lumbreras
SCSergio Camero
Sergio Camero
CSClara M Santiveri
Clara M Santiveri
YMYasmina Mirassou
Yasmina Mirassou
JPJosé Manuel Pérez-Cañadillas
José Manuel Pérez-Cañadillas
Heterodimerization of RNA binding proteins Nrd1 and Nab3 is essential to communicate the RNA recognition in the nascent transcript with the Nrd1 recognition of the Ser5-phosphorylated Rbp1 C-terminal domain in RNA polymerase II. The structure of a Nrd1–Nab3 chimera reveals the basis of heterodimerization, filling a missing gap in knowledge of this system. The free form of the Nrd1 interaction domain of Nab3 (NRID) forms a multi-state three-helix bundle that is clamped in a single conformation upon complex formation with the Nab3 interaction domain of Nrd1 (NAID). The latter domain forms two long helices that wrap around NRID, resulting in an extensive protein–protein interface that would explain the highly favorable free energy of heterodimerization. Mutagenesis of some conserved hydrophobic residues involved in the heterodimerization leads to temperature-sensitive phenotypes, revealing the importance of this interaction in yeast cell fitness. The Nrd1–Nab3 structure resembles the previously reported Rna14/Rna15 heterodimer structure, which is part of the poly(A)-dependent termination pathway, suggesting that both machineries use similar structural solutions despite they share little sequence homology and are potentially evolutionary divergent.

Verified
Journal Article
Open access
PDF file
BCBelén Chaves-Arquero
Belén Chaves-Arquero
CPCecilia Persson
Cecilia Persson
NMNekane Merino
Nekane Merino
JCJulen Tomás Cortázar
Julen Tomás Cortázar
ARAdriana L. Rojas
Adriana L. Rojas
Francisco BlancoFrancisco Blanco
Francisco Blanco
Salp15 is one of the proteins in the saliva of the tick Ixodes scapularis. Together with other biomolecules injected into the mammalian host at the biting site, it helps the tick to sustain its blood meal for days. Salp15 interferes with the cellular immune response of the mammalian host by inhibiting the activation of CD4+ T-lymphocytes. This function is co-opted by pathogens that use the tick as a vector and invade the host when the tick bites, such as Borrelia burgdorferi, the causative agent of Lyme borreliosis. Because of the immunity-suppressing role of Salp15, it has been proposed as a candidate for therapeutic applications in disorders of the immune system. The protein is produced as a 135-residue long polypeptide and secreted without its N-terminal signal 1–21 sequence. Detailed structural studies on Salp15 are lacking because of the difficulty in producing large amounts of the folded protein. We report the production of Salp15 and its structural analysis by NMR. The protein is monomeric and contains a flexible N-terminal region followed by a folded domain with mixed α + β secondary structures. Our results are consistent with a three-dimensional structural model derived from AlphaFold, which predicts the formation of three disulfide bridges and a free C-terminal cysteine.